Core Viewpoint - China General Nuclear Power Technology Co., Ltd. (000881.SZ) expects a loss of 240 million to 340 million yuan in 2025, with a non-recurring loss projected between 320 million to 450 million yuan, indicating ongoing financial challenges as the company invests in market-oriented development and technology applications in healthcare and industrial sectors [1] Financial Performance - The company anticipates a negative net profit for the reporting period due to continued investments in incubation and early-stage business operations [1] - The healthcare segment, particularly in proton therapy equipment and isotope business, has seen an increase in losses compared to the previous year due to heightened R&D and marketing expenditures [1] Asset Management - The company is conducting a comprehensive review and impairment testing of its assets, planning to make provisions for potential asset impairments [1] Non-Recurring Gains and Losses - There has been a decline in non-recurring gains and losses compared to the previous year, primarily due to reduced government subsidies and equity disposal gains recognized in the current period [1]
中广核技(000881.SZ):预计2025年亏损2.4亿元至3.4亿元